{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Search results for "EU ORPHAN DRUG|Positive" in comments (approximate match)
Status:
Investigational
Source:
NCT03867682: Phase 1/Phase 2 Interventional Recruiting Acute Myeloid Leukemia
(2020)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03588026: Phase 3 Interventional Completed Paroxysmal Nocturnal Hemoglobinuria (PNH)
(2018)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT01480479: Phase 3 Interventional Completed Glioblastoma
(2011)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03943589: Phase 2 Interventional Completed Guillain-Barré Syndrome (GBS)
(2019)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT01081691: Phase 1 Interventional Completed Healthy
(2010)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT00418795: Phase 2/Phase 3 Interventional Completed Acute Intermittent Porphyria
(2003)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03578809: Phase 2 Interventional Completed ST Elevation Myocardial Infarction
(2018)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03512314: Phase 3 Interventional Completed XIAP Deficiency
(2018)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03587311: Phase 2 Interventional Active, not recruiting Fallopian Tube Endometrioid Adenocarcinoma
(2018)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT02472977: Phase 1/Phase 2 Interventional Terminated Solid Tumor
(2015)
Source URL:
Class:
PROTEIN
